Canada markets closed

Zomedica Corp. (ZOM)

NYSE American - NYSE American Delayed Price. Currency in USD
Add to watchlist
0.1459+0.0019 (+1.32%)
At close: 04:00PM EDT
0.1459 0.00 (0.00%)
After hours: 07:59PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 142.97M
Enterprise Value 38.52M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)5.96
Price/Book (mrq)0.55
Enterprise Value/Revenue 1.60
Enterprise Value/EBITDA -3.23

Trading Information

Stock Price History

Beta (5Y Monthly) 0.98
52-Week Change 3-31.13%
S&P500 52-Week Change 327.86%
52 Week High 30.2450
52 Week Low 30.1200
50-Day Moving Average 30.1335
200-Day Moving Average 30.1723

Share Statistics

Avg Vol (3 month) 35.54M
Avg Vol (10 day) 34.23M
Shares Outstanding 5979.95M
Implied Shares Outstanding 6979.95M
Float 8962.81M
% Held by Insiders 11.64%
% Held by Institutions 19.17%
Shares Short (Mar 15, 2024) 457.82M
Short Ratio (Mar 15, 2024) 49.47
Short % of Float (Mar 15, 2024) 46.00%
Short % of Shares Outstanding (Mar 15, 2024) 45.90%
Shares Short (prior month Feb 15, 2024) 457.05M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2022
Most Recent Quarter (mrq)Sept 30, 2023

Profitability

Profit Margin -62.20%
Operating Margin (ttm)-93.71%

Management Effectiveness

Return on Assets (ttm)-5.68%
Return on Equity (ttm)-5.64%

Income Statement

Revenue (ttm)24.01M
Revenue Per Share (ttm)0.02
Quarterly Revenue Growth (yoy)32.90%
Gross Profit (ttm)N/A
EBITDA -19.68M
Net Income Avi to Common (ttm)-14.93M
Diluted EPS (ttm)-0.0200
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)106.21M
Total Cash Per Share (mrq)0.11
Total Debt (mrq)1.75M
Total Debt/Equity (mrq)0.67%
Current Ratio (mrq)17.12
Book Value Per Share (mrq)0.27

Cash Flow Statement

Operating Cash Flow (ttm)-13.34M
Levered Free Cash Flow (ttm)-19.77M